# Priyanka Mitra > Priyanka Mitra is a Series A investor at M12 - Microsoft's Venture Fund backing Artificial Intelligence. See 17 investments, check sizes, portfolio. Updated… - Type: Angel Investor - Fund: [M12 - Microsoft's Venture Fund](https://shizune.co/investors/profile/m12) - Location: San Francisco, United States - Total investments: 17 - Last investment: Jul 2023 - Lead investor: 59% - Last updated: Aug 2026 - LinkedIn: https://www.linkedin.com/in/priyanka-shreya-mitra/ Priyanka Mitra is a Series A investor at M12 - Microsoft's Venture Fund in San Francisco focused on Artificial Intelligence and Software. Priyanka Mitra is based out of San Francisco, California and is the Partner of M12 - Microsoft's Venture Fund. Priyanka Mitra attended the Harvard University. ## Investment focus ### Industry | Industry | Investments | Share | | --- | --- | --- | | Artificial Intelligence | 5 | 29% | | Software | 4 | 24% | | Health Care | 3 | 18% | | Machine Learning | 3 | 18% | | SaaS | 2 | 12% | 26 industries tracked in total. ### Stage | Stage | Investments | Share | | --- | --- | --- | | Series A | 4 | 24% | | Seed | 3 | 18% | | Funding Round | 2 | 12% | | Series D | 1 | 6% | ### Country | Country | Investments | Share | | --- | --- | --- | | United States | 5 | 29% | | Canada | 2 | 12% | | United Kingdom | 1 | 6% | ## Investments | Company | Description | Amount | Stage | Date | Website | | --- | --- | --- | --- | --- | --- | | ToolJet | ToolJet is an open-source low-code framework used to build and deploy custom internal tools. Its platform builds internal tools in minutes using pre-built components and can connect to databases, services, cloud storage, and custom API endpoints to fetch data and take action. | | | Jul 17, 2023 | | | ToolJet | ToolJet is an open-source low-code framework used to build and deploy custom internal tools. Its platform builds internal tools in minutes using pre-built components and can connect to databases, services, cloud storage, and custom API endpoints to fetch data and take action. | | | Jul 17, 2023 | | | Private AI | Private AI is developing privacy-preserving machine learning and natural language processing tools. We envision a future in which private, secure, and seamless data analysis enhances creative software development.Our technology is the best in the world at finding, redacting, and generating synthetic PII within semi- and unstructured datasets. Wehit 99.5%+ accuracy in 47+ languages across 50+ different entity types, and deploy as a Docker container within our partners' existing infrastructure so that their data never leaves their environment and is never shared with us. Ever.Try the web demo here: http://demo.private-ai.com/ | $8M | Series A | Nov 17, 2022 | | | Private AI | Private AI is developing privacy-preserving machine learning and natural language processing tools. We envision a future in which private, secure, and seamless data analysis enhances creative software development.Our technology is the best in the world at finding, redacting, and generating synthetic PII within semi- and unstructured datasets. Wehit 99.5%+ accuracy in 47+ languages across 50+ different entity types, and deploy as a Docker container within our partners' existing infrastructure so that their data never leaves their environment and is never shared with us. Ever.Try the web demo here: http://demo.private-ai.com/ | $8M | Series A | Nov 17, 2022 | | | iLoF | iLoF - Intelligent Lab on Fiber is a patented photonics and Artificial Intelligence system identifies unique features of various gold-standard biomarkers, capturing their signature on a cloud-based library. | $4.1M | | Jul 28, 2022 | | | iLoF | iLoF - Intelligent Lab on Fiber is a patented photonics and Artificial Intelligence system identifies unique features of various gold-standard biomarkers, capturing their signature on a cloud-based library. | $4.1M | | Jul 28, 2022 | | | iLoF | iLoF - Intelligent Lab on Fiber is a patented photonics and Artificial Intelligence system identifies unique features of various gold-standard biomarkers, capturing their signature on a cloud-based library. | $4.1M | Seed | Jul 28, 2022 | | | MedMe Health | MedMe Health is a patient care platform to help pharmacists schedule, conduct, and track clinical services at scale - both virtually and on-site at your pharmacy. | $2.7M | Seed | Mar 17, 2022 | | | MedMe Health | MedMe Health is a patient care platform to help pharmacists schedule, conduct, and track clinical services at scale - both virtually and on-site at your pharmacy. | $2.7M | Seed | Mar 17, 2022 | | | Wallaroo | Wallaroo is a purpose-built platform for last-mile ML. It provides a simple, secure, and scalable deployment capability that fits an end-to-end workflow. | $25M | Series A | Feb 09, 2022 | | 10 of 17 investments shown. ## Co-investors - [M12 - Microsoft's Venture Fund](https://shizune.co/investors/profile/microsoftventures) — VC Fund, 9 deals together - [M12 - Microsoft's Venture Fund](https://shizune.co/investors/profile/m12) — VC Fund, 7 deals together - [Accel](https://shizune.co/investors/profile/accel) — VC Fund, 4 deals together - [Blue Owl Capital Corporation](https://shizune.co/investors/profile/owl-rock-capital-partners) — VC Fund, 4 deals together - [Alter Venture Partners](https://shizune.co/investors/profile/alter-venture-partners) — VC Fund, 3 deals together - [Differential Ventures](https://shizune.co/investors/profile/differential-ventures) — VC Fund, 3 deals together ## About M12 - Microsoft's Venture Fund VC Fund · San Francisco, United States M12 - Microsoft’s venture fund, invests in early-stage enterprise software companies with a focus on AI, cloud infrastructure, cybersecurity, developer tools, vertical SaaS, and Web3/Gaming. Since 2016, M12 has invested in over 100 companies, helping startups accelerate growth with unparalleled access to Microsoft. 5 contacts available at M12 - Microsoft's Venture Fund. | Name | Title | Profile | | --- | --- | --- | | Peter Lenke | Managing Partner | https://shizune.co/investors/profile/peter-lenke | | Priyanka Mitra | Partner | https://shizune.co/investors/profile/priyanka-mitra | | Todd Graham | Managing Partner | https://shizune.co/investors/profile/todd-graham | | James Wu | Partner | https://shizune.co/investors/profile/james-wu-855c | | John Vela | Director of Portfolio Development | https://shizune.co/investors/profile/john-vela-77d2 | ## Similar investors ### Similar stage - [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund - [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund - [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund ## FAQ ### What does Priyanka Mitra invest in? Priyanka Mitra invests primarily in Artificial Intelligence, Software and Health Care startups, most often at Series A and Seed stage. Most of the 17 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio. ### When did Priyanka Mitra last invest? The most recent investment recorded for Priyanka Mitra closed in Jul 2023. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly. ### Is Shizune's investor data accurate? Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page. # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co